In line with the pathological role of the SCUBE3-TGF-β signaling axis, our collaborative studies showed that soluble SCUBE3 can act via TGF-β to stimulate negative outcomes in lung cancer cells. This evidence concerns the gene TGFB1 and lung cancer.